SVP Regulatory Development
Darin J. Weber, PhD joined the Company as Senior Vice President of Regulatory Development in September 2020. He is responsible leading development and implementation of the Company’s regulatory strategy in all markets, worldwide. Weber has been working in the field of cell and gene advanced therapies for more than 20 years having previously served in senior leadership roles at Medeor Therapeutics and Mesoblast. Weber previously was a Senior Consultant for cellular and gene therapies at Biologics Consulting Group, LLC. Prior to joining industry, Weber held positions of increasing responsibility at the FDA’s Center for Biologics Evaluation and Research, including as Chief of Cellular Therapies Branch in the Office of Cellular, Tissues and Gene Therapies, (now known as the Office of Tissues and Advanced Therapies). He is a long serving member on United States Pharmacopeia (USP) expert committees for human tissues and advanced therapies. Weber received his BS from The Evergreen State College and a PhD in Biochemistry and Biophysics from Oregon State University.